Stay updated on Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check8 days agoChange DetectedA sitewide NIH banner announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.4%

- Check15 days agoChange DetectedThe website footer revision changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check22 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry, v3.7.0, has been added to the study record history and the old entry, v3.6.6, has been removed, updating the history to reflect the latest revision.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a newer version of the page history.SummaryDifference0.1%

Stay in the know with updates to Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.